Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 4/20 | 0.68 |
| ▸ | CALCR | P30988 | 7/20 | 0.66 |
| ▸ | RAMP3 | O60896 | 3/20 | 0.66 |
| ▸ | F2 | P00734 | 4/20 | 0.65 |
| ▸ | NPY2R | P49146 | 3/20 | 0.63 |
| ▸ | NPY4R | P50391 | 3/20 | 0.63 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.63 |
| ▸ | NPY1R | P25929 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30818417 | 0.94 | TFPI (0.68) | TFPICALCRRAMP3NPY2RNPY4R | |
| SCHEMBL30818413 | 0.93 | CALCR (0.69) | TFPICALCRRAMP3NPY2RNPY4R | |
| SCHEMBL30818412 | 0.93 | CALCR (0.69) | TFPICALCRRAMP3NPY2RNPY4R | |
| SCHEMBL29783627 | 0.92 | CALCR (0.72) | TFPICALCRRAMP3NPY2RNPY4R | |
| SCHEMBL29783639 | 0.92 | CALCR (0.72) | TFPICALCRRAMP3NPY2RNPY4R | |
| SCHEMBL29783634 | 0.92 | CALCR (0.72) | TFPICALCRRAMP3NPY2RNPY4R | |
| SCHEMBL30818416 | 0.92 | CALCR (0.69) | TFPICALCRRAMP3NPY2RNPY4R | |
| SCHEMBL29783622 | 0.92 | CALCR (0.75) | TFPICALCRRAMP3 | |
| SCHEMBL29860218 | 0.92 | MC4R (0.64) | TFPICALCRRAMP3F2NPY2R | |
| SCHEMBL29588650 | 0.92 | MC4R (0.64) | TFPICALCRRAMP3F2NPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250290128-A1 | METHOD OF MEASURING MICROSATELLITE LENGTH VARIATIONS | COLD SPRING HARBOR LABORATORY (US) | 2025-09-18 | — | — | US | disclosed |
| US-20250177473-A1 | PEPTIDE REGULATORS OF METABOLISM | METABICO INC (US) | 2025-06-05 | — | — | US | disclosed |
| EP-4479076-A2 | PEPTIDE REGULATORS OF METABOLISM | Metabico, Inc. (US) | 2024-12-25 | — | — | EP | disclosed |
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2024-11-14 | — | — | US | disclosed |
| CN-107884146-B | Equipment medium leakage detection device | 江苏核电有限公司 | 2024-05-14 | — | — | CN | disclosed |
| US-11857600-B2 | GPCR heteromer inhibitors and uses thereof | GPCR THERAPEUTICS, INC. (KR) | 2024-01-02 | — | — | US | disclosed |
| CN-116901768-A | Bidirectional charging pile and control method thereof | 阳光乐充科技有限公司 | 2023-10-20 | — | — | CN | disclosed |
| WO-2023159125-A2 | PEPTIDE REGULATORS OF METABOLISM | METABICO, INC. (US) | 2023-08-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | SCTR, GIPR, APLNR | TFPI 1309/4885CALCR 118/4885RAMP3 410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.